Company Overview of Protea Biosciences Group, Inc
Protea Biosciences Group, Inc., molecular information company, develops and commercializes proprietary life science technologies, products, and services to identify the molecules that are produced by living cells and various life forms. The company provides molecular information services for the identification of small and large molecules; and tissue analytics services to create tissue-based molecular profiles. It also offers laser ablation electrospray ionization, a bioanalytical instrument platform that enables the identification of proteins, lipids, and metabolites in tissue, cells, and biofluids, such as serum and urine with minimal or without any sample preparation prior to analysis. It...
955 Hartman Run Road
Morgantown, WV 26507
Founded in 2001
Key Executives for Protea Biosciences Group, Inc
Chairman, Chief Executive Officer and President
Total Annual Compensation: $240.0K
Chief Financial Officer
Total Annual Compensation: $145.6K
Chief Operating Officer and Vice President of Operations
Total Annual Compensation: $210.0K
Chief Science Officer and Vice President of Research & Development
Total Annual Compensation: $153.9K
Compensation as of Fiscal Year 2014.
Protea Biosciences Group, Inc Key Developments
Protea Biosciences Group Announces Memorandum of Understanding with Agilent Technologies
Dec 8 15
Protea Biosciences Group Inc. announced that it is collaborating with Agilent Technologies Inc. to address customer challenges within existing Biopharma bioanalytical workflows in order to meet the emerging needs of the growing biopharmaceutical industry. Under Terms of the Agreement, a Memorandum of Understanding (MOU), Protea, using Agilent instrumentation combined with its technology, will develop workflows that focus on developing new methods for the field of metabolomics.
Protea Biosciences Group, Inc Proposes Amendments to Certificate of Incorporation
Oct 14 15
Protea Biosciences Group Inc. proposed amendments to its certificate of incorporation, as amended (charter amendment), to effect a reverse stock split of common stock, $0.0001 par value per share (common stock), within a range of no less than 1:15 and no more than 1:25, with such ratio to be determined by the Board of Directors, in its sole discretion (reverse split), and with such Reverse Split to be effective at such time and date within one year after the date such action is approved by the stockholders, if at all, as determined by the Board of Directors in its sole discretion.
Protea Biosciences Group, Inc. Announces New Silicon Chip Technology
Jun 1 15
Protea Biosciences Group Inc. announced new, silicon chip technology that enables the rapid identification and quantitation of small molecules in biofluids. The announcement was made at the 63rd American Society of Mass Spectrometry (ASMS) Conference on Mass Spectrometry and Allied Topics, held in St. Louis, MO. Known as REDIchip ("Resonance-Enhanced Desorption Ionization"), the product employs a patented, "nanopost array" (NAPA) nanotechnology invented in the laboratory of Prof. Akos Vertes, PhD., Department of Chemistry, The George Washington University, and exclusively licensed to Protea. REDIchip technology was developed by Protea in conjunction with a $14 million DARPA cooperative research agreement led by The George Washington University and including GE Global Research and SRI International. The project goal is to develop new tools to elucidate the mechanism of action of a threat agent, drug, biologic or chemical on living cells within 30 days from exposure. Uncovering the mechanism of action of such agents in 30 days compared to the years currently required will enhance and support the development of effective threat mitigations and countermeasures. REDIchip is formatted as a disposable, single use, 96 spot, target plate, suitable for simple and complex biological mixtures, and compatible with most standard MALDI-MS instrument systems.
Similar Private Companies By Industry
Recent Private Companies Transactions
August 27, 2015
May 22, 2015
April 6, 2015